dipivefrin has been researched along with Intraocular Pressure in 60 studies
dipivefrin: used in treatment of both primary & open angle glaucoma; RN given refers to (+-)-isomer
dipivefrin : The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.
Intraocular Pressure: The pressure of the fluids in the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect on intraocular pressure (IOP) and aqueous flare of topical applications of latanoprost and dipivefrin alone or combined." | 9.08 | Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. ( Alm, A; Mäepea, O; Widengård, I, 1998) |
| "In this double-blind prospective trial the efficacy of lowering the intraocular pressure of l-moprolol given alone and in combination with dipivefrin was tested." | 9.07 | The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension. ( Barbieri, P; Bujtar, E; Orzalesi, N; Rossetti, L; Velati, P, 1994) |
| "The authors compared the additive intraocular pressure (IOP)-lowering effects of two different topical medications, apraclonidine hydrochloride and dipivefrin hydrochloride, when used in conjunction with timolol maleate." | 9.06 | Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate. ( Morrison, JC; Robin, AL, 1989) |
| " Latanoprost produces an additional reduction of intraocular pressure (IOP) when used in combination with timolol, pilocarpine, acetazolamide and dipivefrin." | 8.79 | The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents. ( Alm, A; Greve, E; Hoyng, PF; Rulo, A; Watson, P, 1997) |
| "The pH and dose dependencies of topically applied dipivefrine hydrochloride (DPE) on intraocular pressure (IOP) reduction and mydriasis were compared with those of epinephrine bitartrate (EPI) in normal rabbits." | 7.67 | pH dependency of effect of topically applied dipivefrine hydrochloride on intraocular pressure and pupil size in rabbits: comparative studies with epinephrine. ( Iso, T; Sasano, M; Yamauchi, H, 1988) |
| "Thirty patients with ocular hypertension or open-angle glaucoma were tested to see if, and to what extent, guanethidine/dipivefrin and pilocarpine produced a supplementary reduction in intraocular pressure." | 7.67 | [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure]. ( Dausch, D; Ober, M; Scharrer, A, 1987) |
| "The author considers that the combined use of pilocarpine and Dipivefrin (Thiloadren) represents an additional effective method of regulating pressure as physiologically as possible in glaucomatous eyes with trophic disorders, thus further reducing the need for surgery." | 7.66 | [Treatment of glaucoma with a pilocarpine-dipivefrin combination (author's transl)]. ( Niedermeier, S, 1981) |
| "In a randomized clinical trial, 100 consecutive subjects with ocular hypertension or high-tension primary open-angle glaucoma in at least one eye were randomly assigned to either group A, which was administered timolol 0." | 5.08 | Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans. ( Gandolfi, SA; Vecchi, M, 1996) |
| "To investigate the effect on intraocular pressure (IOP) and aqueous flare of topical applications of latanoprost and dipivefrin alone or combined." | 5.08 | Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. ( Alm, A; Mäepea, O; Widengård, I, 1998) |
| "In this double-blind prospective trial the efficacy of lowering the intraocular pressure of l-moprolol given alone and in combination with dipivefrin was tested." | 5.07 | The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension. ( Barbieri, P; Bujtar, E; Orzalesi, N; Rossetti, L; Velati, P, 1994) |
| "The authors compared the additive intraocular pressure (IOP)-lowering effects of two different topical medications, apraclonidine hydrochloride and dipivefrin hydrochloride, when used in conjunction with timolol maleate." | 5.06 | Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate. ( Morrison, JC; Robin, AL, 1989) |
| " Latanoprost produces an additional reduction of intraocular pressure (IOP) when used in combination with timolol, pilocarpine, acetazolamide and dipivefrin." | 4.79 | The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents. ( Alm, A; Greve, E; Hoyng, PF; Rulo, A; Watson, P, 1997) |
| "Thirteen patients with normal-tension glaucoma with a cystic filtering bleb who had undergone unilateral trabeculectomy with mitomycin C only once at least 1 year previously were subjected to the study." | 3.69 | Epithelial barrier function of the filtering bleb conjunctiva and the cornea after trabeculectomy with mitomycin C. ( Haque, MS; Kinoshita, S; Kitazawa, Y; Komuro, A; Mochizuki, K; Taniguchi, T; Yamamoto, T; Yokoi, N, 1996) |
| " Nine patients with ocular hypertension receiving treatment with timolol were entered into the study." | 3.68 | Long-term drift and timolol therapy: possible role for pulsed therapy. ( Batterbury, M; Harding, SP; Wong, D, 1992) |
| "The intraocular pressure (IOP) and pupillary effects of dipivalyl esters of epinephrine and alpha-methylepinephrine were compared after topical application in conscious rabbits." | 3.68 | Ocular effects of dipivalyl esters of epinephrine and alpha-methylepinephrine. ( Gherezghiher, T; Koss, MC, 1990) |
| "1% dipivefrin hydrochloride was instilled in a randomized, double-blind fashion in eyes treated with timolol maleate no change in heart rate, intraocular pressure or rate of aqueous outflow was noted." | 3.67 | Cardiovascular effects of epinephrine and dipivefrin in patients using timolol: a single-dose study. ( Blondeau, P; Côté, M, 1984) |
| "The pH and dose dependencies of topically applied dipivefrine hydrochloride (DPE) on intraocular pressure (IOP) reduction and mydriasis were compared with those of epinephrine bitartrate (EPI) in normal rabbits." | 3.67 | pH dependency of effect of topically applied dipivefrine hydrochloride on intraocular pressure and pupil size in rabbits: comparative studies with epinephrine. ( Iso, T; Sasano, M; Yamauchi, H, 1988) |
| "Thirty patients with ocular hypertension or open-angle glaucoma were tested to see if, and to what extent, guanethidine/dipivefrin and pilocarpine produced a supplementary reduction in intraocular pressure." | 3.67 | [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure]. ( Dausch, D; Ober, M; Scharrer, A, 1987) |
| "A survey of the literature concerning the interaction of timolol and epinephrine in lowering intraocular pressure, and a study comparing the efficacy of timolol and dipivefrin (a prodrug of epinephrine) to that of timolol and pilocarpine are presented." | 3.66 | Combined timolol and epinephrine therapy for open angle glaucoma. ( Hurvitz, L; Knupp, JA; Mandell, AI; Shields, MB; Spaeth, GL, 1983) |
| " Relative to its less lipid soluble parent compound, dipivefrin has been shown in clinical trials to control intraocular pressure effectively at concentrations 10-20 times less than epinephrine with a resultant decreased incidence of ocular and systemic side effects." | 3.66 | An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma. ( Garzia, R, 1982) |
| "The author considers that the combined use of pilocarpine and Dipivefrin (Thiloadren) represents an additional effective method of regulating pressure as physiologically as possible in glaucomatous eyes with trophic disorders, thus further reducing the need for surgery." | 3.66 | [Treatment of glaucoma with a pilocarpine-dipivefrin combination (author's transl)]. ( Niedermeier, S, 1981) |
| "05% dipivefrin every 12 hours might be an adequate dosage for maximal effect." | 2.67 | Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications. ( Sharir, M; Zimmerman, TJ, 1994) |
| "The prevalence of open angle glaucoma is disproportionately high in the African American population." | 2.67 | Levobunolol compared to dipivefrin in African American patients with open angle glaucoma. ( Drake, MV; Goodwin, L; Harris, D; Wilson, MR, 1993) |
| "1% dipivefrin are at the top of the dose-response curve." | 2.67 | Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion. ( Fuqua, M; Nardin, GF; Sharir, M; Zimmerman, TJ, 1992) |
| "Dipivefrin is a safe, effective, and well-tolerated alternative to epinephrine in the treatment of elevated IOP." | 2.65 | Dipivefrin: current concepts. ( Becker, B; Goldberg, I; Kass, MA; Kolker, AE, 1980) |
| "The mean pretreatment intraocular pressure (IOP), 40." | 1.29 | Transscleral neodymium:YAG laser cyclophotocoagulation for end-stage glaucoma, refractory glaucoma, and painful blind eyes. ( al-Ghamdi, S; al-Jadaan, I; al-Obeidan, S; Tomey, KF, 1993) |
| "D,L-dipivefrin hydrochloride was administered bilaterally to rabbit eyes five or 150 minutes after unilateral application of a cholinesterase inhibitor." | 1.27 | Enzymatic and nonenzymatic hydrolysis of D,L-dipivefrin. ( Barker, LA; Cohen, G; Lewis, DE; Mindel, JS, 1984) |
| "When dipivefrin was administered with echothiophate plus phentolamine, there was an immediate hypotensive effect." | 1.26 | The effect of echothiophate on the biphasic response of rabbit ocular pressure to dipivefrin. ( Goldfarb, J; Kharlamb, AB; Koenigsberg, AM; Mindel, JS; Orellana, J, 1982) |
| "Dipivefrin was administered singly and in combination with echothiophate to 24 adult rabbits." | 1.26 | Dipivefrin and echothiophate: contraindications to combined use. ( Abramovsky, I; Mindel, JS, 1979) |
| "1%) developed adverse external ocular side effects severe enough to require that the drug be discontinued." | 1.26 | External ocular toxicity of dipivalyl epinephrine. ( Leibowitz, HM; Theodore, J, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (50.00) | 18.7374 |
| 1990's | 26 (43.33) | 18.2507 |
| 2000's | 3 (5.00) | 29.6817 |
| 2010's | 1 (1.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura-Shibasaki, M | 1 |
| Latief, MA | 1 |
| Ko, JA | 1 |
| Funaishi, K | 1 |
| Kiuchi, Y | 1 |
| Lin, JC | 1 |
| Samuel, F | 1 |
| Katz, LJ | 1 |
| Spaeth, GL | 2 |
| Hoop, J | 1 |
| Cantor, LB | 1 |
| Călugăru, M | 1 |
| Călugăru, D | 1 |
| Mindel, JS | 4 |
| Koenigsberg, AM | 1 |
| Kharlamb, AB | 1 |
| Goldfarb, J | 1 |
| Orellana, J | 2 |
| West, RH | 3 |
| Cebon, L | 2 |
| Gillies, WE | 4 |
| Knupp, JA | 1 |
| Shields, MB | 1 |
| Mandell, AI | 1 |
| Hurvitz, L | 1 |
| Cohen, G | 1 |
| Barker, LA | 1 |
| Lewis, DE | 1 |
| Blondeau, P | 1 |
| Côté, M | 1 |
| Goldberg, I | 1 |
| Kolker, AE | 1 |
| Kass, MA | 1 |
| Becker, B | 1 |
| Frumar, KD | 3 |
| McGuinness, R | 3 |
| Kerr, CR | 1 |
| Hass, I | 1 |
| Drance, SM | 1 |
| Walters, MB | 1 |
| Schulzer, M | 1 |
| Garzia, R | 1 |
| Niedermeier, S | 1 |
| Yablonski, ME | 1 |
| Tavitian, HO | 1 |
| Podos, SM | 2 |
| Keates, EU | 1 |
| Stone, RA | 1 |
| Rossetti, L | 1 |
| Barbieri, P | 1 |
| Velati, P | 1 |
| Bujtar, E | 1 |
| Orzalesi, N | 1 |
| Alimgil, ML | 1 |
| Erda, S | 1 |
| Benian, O | 1 |
| Shao, H | 1 |
| Sun, XY | 1 |
| Bai, FG | 1 |
| Sharir, M | 2 |
| Zimmerman, TJ | 3 |
| Drake, MV | 1 |
| Wilson, MR | 1 |
| Harris, D | 1 |
| Goodwin, L | 1 |
| Michelson, G | 1 |
| Groh, MJ | 1 |
| al-Ghamdi, S | 1 |
| al-Obeidan, S | 1 |
| Tomey, KF | 1 |
| al-Jadaan, I | 1 |
| Albracht, DC | 1 |
| LeBlanc, RP | 1 |
| Cruz, AM | 1 |
| Lamping, KA | 1 |
| Siegel, LI | 1 |
| Stern, KL | 1 |
| Kelley, EP | 1 |
| Stoecker, JF | 1 |
| Gandolfi, SA | 2 |
| Vecchi, M | 1 |
| Taniguchi, T | 1 |
| Yamamoto, T | 1 |
| Mochizuki, K | 1 |
| Haque, MS | 1 |
| Kitazawa, Y | 1 |
| Yokoi, N | 1 |
| Komuro, A | 1 |
| Kinoshita, S | 1 |
| Werner, E | 1 |
| Koseki, N | 1 |
| Araie, M | 1 |
| Shirato, S | 1 |
| Yamagami, J | 1 |
| Hoyng, PF | 1 |
| Rulo, A | 1 |
| Greve, E | 1 |
| Watson, P | 1 |
| Alm, A | 2 |
| Werner, EB | 1 |
| Widengård, I | 1 |
| Mäepea, O | 1 |
| Brooks, AM | 2 |
| Lannek, EB | 1 |
| Miller, PE | 1 |
| Kohn, AN | 1 |
| Moss, AP | 1 |
| Hargett, NA | 1 |
| Ritch, R | 1 |
| Smith, H | 1 |
| Abramovsky, I | 1 |
| Theodore, J | 1 |
| Leibowitz, HM | 1 |
| Gwin, RM | 1 |
| Gelatt, KN | 1 |
| Gum, GG | 1 |
| Peiffer, RL | 1 |
| Batterbury, M | 1 |
| Harding, SP | 1 |
| Wong, D | 1 |
| Ophir, A | 1 |
| Ticho, U | 1 |
| Nardin, GF | 1 |
| Fuqua, M | 1 |
| Brown, RH | 1 |
| Shin, DH | 2 |
| Tsai, CS | 1 |
| Parrow, KA | 2 |
| Kim, C | 1 |
| Wan, JY | 1 |
| Shi, DX | 2 |
| Chang, JS | 1 |
| Lee, DA | 1 |
| Petursson, G | 1 |
| Spaeth, G | 1 |
| Hoskins, HD | 1 |
| Mills, R | 1 |
| Brown, R | 1 |
| Kass, M | 1 |
| Lue, J | 1 |
| Gherezghiher, T | 1 |
| Koss, MC | 1 |
| Robin, AL | 4 |
| Hong, YJ | 1 |
| McCarty, B | 1 |
| Morrison, JC | 2 |
| Dandona, L | 1 |
| Quigley, HA | 1 |
| Leopold, IH | 1 |
| Duzman, E | 1 |
| Soll, DB | 1 |
| Saxon, AM | 1 |
| Yamauchi, H | 1 |
| Sasano, M | 1 |
| Iso, T | 1 |
| Allen, RC | 1 |
| Long, D | 1 |
| Novack, GD | 1 |
| Lue, JC | 1 |
| Kaplan, G | 1 |
| Ober, M | 2 |
| Scharrer, A | 2 |
| Dausch, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000144] | Phase 3 | 0 participants | Interventional | 1984-01-31 | Completed | ||
| Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma[NCT02679482] | 36 participants (Anticipated) | Observational | 2014-09-30 | Recruiting | |||
| External Micropulse Diode Laser Transscleral Trabeculoplasty(EMDLT) For Severe Open Angle Glaucoma[NCT00443664] | Early Phase 1 | 30 participants (Anticipated) | Interventional | 2006-06-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for dipivefrin and Intraocular Pressure
| Article | Year |
|---|---|
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Dr | 2004 |
The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents.
Topics: Acetazolamide; Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Carbonic Anhydrase Inhibit | 1997 |
Combination therapy.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Epinephrine; Glaucoma; Humans; Intraocular P | 1991 |
Observations on the pharmacology of glaucoma.
Topics: Adenylyl Cyclase Inhibitors; Adrenal Cortex Hormones; Adrenergic alpha-Agonists; Adrenergic beta-Ago | 1986 |
24 trials available for dipivefrin and Intraocular Pressure
| Article | Year |
|---|---|
The effect of topical glaucoma medications evaluated by perimetry.
Topics: Administration, Topical; Antihypertensive Agents; Betaxolol; Clonidine; Epinephrine; Glaucoma; Human | 2003 |
Dipivefrin: current concepts.
Topics: Absorption; Biotransformation; Clinical Trials as Topic; Cornea; Epinephrine; Glaucoma; Humans; Hydr | 1980 |
A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Female; Glaucoma; Humans; I | 1981 |
Cardiovascular effects of epinephrine and dipivalyl epinephrine applied topically to the eye in patients with glaucoma.
Topics: Aged; Blood Pressure; Cardiovascular System; Clinical Trials as Topic; Double-Blind Method; Epinephr | 1982 |
A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Female; Glaucoma; Humans; I | 1982 |
Dipivefrin and echothiophate. Efficacy of combined use in human beings.
Topics: Drug Therapy, Combination; Echothiophate Iodide; Epinephrine; Fluorometry; Glaucoma; Humans; Intraoc | 1981 |
The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Comb | 1994 |
[The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine].
Topics: Clonidine; Drug Synergism; Drug Therapy, Combination; Epinephrine; Female; Glaucoma, Open-Angle; Hum | 1994 |
Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications.
Topics: Aged; Carbachol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; E | 1994 |
Levobunolol compared to dipivefrin in African American patients with open angle glaucoma.
Topics: Adult; Aged; Black People; Double-Blind Method; Epinephrine; Female; Glaucoma, Open-Angle; Humans; I | 1993 |
Dipivefrin reduces blood flow in the ciliary body in humans.
Topics: Administration, Topical; Adult; Blood Flow Velocity; Ciliary Body; Double-Blind Method; Electrocardi | 1994 |
A double-masked comparison of betaxolol and dipivefrin for the treatment of increased intraocular pressure.
Topics: Aged; Betaxolol; Double-Blind Method; Epinephrine; Female; Glaucoma, Open-Angle; Heart Rate; Humans; | 1993 |
Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Drug Administration Schedule; Drug Tolerance; Epin | 1996 |
[Effect of non-surgical ocular hypotensive therapy in normal-tension glaucoma].
Topics: Carteolol; Drug Therapy, Combination; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Middle Ag | 1997 |
Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.
Topics: Adrenergic Agonists; Aged; Blood-Aqueous Barrier; Conjunctival Diseases; Drug Administration Schedul | 1998 |
Clinical comparison of dipivalyl epinephrine and epinephrine in the treatment of glaucoma.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Female; Glaucoma; Humans; I | 1979 |
Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion.
Topics: Absorption; Cornea; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Glaucoma, Op | 1992 |
The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Labeling; Epinephrine; Female; Glaucoma; Humans; In | 1991 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma.
Topics: Aged; Drug Administration Schedule; Drug Tolerance; Epinephrine; Follow-Up Studies; Glaucoma, Open-A | 1990 |
Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Epinep | 1989 |
Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.
Topics: Adult; Aged; Clinical Trials as Topic; Clonidine; Drug Therapy, Combination; Epinephrine; Eye Diseas | 1989 |
"Outlier" intraocular pressure readings: valid or invalid for statistical analysis?
Topics: Analysis of Variance; Clinical Trials as Topic; Clonidine; Data Interpretation, Statistical; Double- | 1989 |
A combination of levobunolol and dipivefrin for the treatment of glaucoma.
Topics: Drug Combinations; Epinephrine; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Levobunolol; Opt | 1988 |
32 other studies available for dipivefrin and Intraocular Pressure
| Article | Year |
|---|---|
Effects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbits.
Topics: Administration, Topical; Adrenergic Agonists; Animals; Aqueous Humor; Blood-Aqueous Barrier; Brimoni | 2016 |
The effect of echothiophate on the biphasic response of rabbit ocular pressure to dipivefrin.
Topics: Animals; Dose-Response Relationship, Drug; Echothiophate Iodide; Epinephrine; Intraocular Pressure; | 1982 |
Drop attack in glaucoma. The Melbourne experience with topical miotics, adrenergic and neuronal blocking drops.
Topics: Echothiophate Iodide; Epinephrine; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mio | 1983 |
Experience with dipivalyl epinephrine. Its effectiveness, alone or in combination, and its side effects.
Topics: Drug Therapy, Combination; Epinephrine; Glaucoma; Glaucoma, Open-Angle; Headache; Humans; Intraocula | 1983 |
Combined timolol and epinephrine therapy for open angle glaucoma.
Topics: Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Pilocarp | 1983 |
Enzymatic and nonenzymatic hydrolysis of D,L-dipivefrin.
Topics: Animals; Aorta; Aqueous Humor; Catalysis; Cholinesterase Inhibitors; Chromatography, High Pressure L | 1984 |
Cardiovascular effects of epinephrine and dipivefrin in patients using timolol: a single-dose study.
Topics: Aged; Aqueous Humor; Arrhythmias, Cardiac; Blood Pressure; Double-Blind Method; Drug Interactions; D | 1984 |
An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma.
Topics: Cornea; Drug Administration Schedule; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressur | 1982 |
Timolol and dipivalyl epinephrine combination therapy.
Topics: Aged; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Epinephrine; Female; Glaucoma, Ope | 1982 |
[Treatment of glaucoma with a pilocarpine-dipivefrin combination (author's transl)].
Topics: Drug Therapy, Combination; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Pilocarpine | 1981 |
Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Glaucoma; Humans; Intraocular Pressure; | 1981 |
[Comparison of 0.1% dipivalyl epinephrine and 1% epinephrine in patients with glaucoma or ocular hypertension].
Topics: Adolescent; Adult; Epinephrine; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mi | 1994 |
Transscleral neodymium:YAG laser cyclophotocoagulation for end-stage glaucoma, refractory glaucoma, and painful blind eyes.
Topics: Adult; Aged; Aged, 80 and over; Blindness; Ciliary Body; Epinephrine; Follow-Up Studies; Glaucoma; H | 1993 |
Epithelial barrier function of the filtering bleb conjunctiva and the cornea after trabeculectomy with mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Conjunctiva; Cornea; Epinephrine; Epithelium; Female; Fluorescein | 1996 |
A topical prostaglandin for glaucoma.
Topics: Administration, Topical; Adrenergic Agents; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibito | 1996 |
Progressive normal-tension glaucoma. I. Analysis.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Aged; Disease Progression; Epinephrine; Female; Gl | 1996 |
Treatment of progressive normal-tension glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Disease Progression; Epinephrine; Female | 1997 |
An in-service investigation of the additive effect of topical adrenergic agonists and beta-blockers.
Topics: Administration, Topical; Adrenergic Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and | 1998 |
Development of glaucoma after phacoemulsification for removal of cataracts in dogs: 22 cases (1987-1997).
Topics: Animals; Antihypertensive Agents; Cataract; Dog Diseases; Dogs; Epinephrine; Female; Glaucoma; Intra | 2001 |
Dipivefrin and echothiophate: contraindications to combined use.
Topics: Administration, Topical; Animals; Biotransformation; Drug Combinations; Drug Interactions; Echothiop | 1979 |
External ocular toxicity of dipivalyl epinephrine.
Topics: Administration, Topical; Aged; Conjunctiva; Conjunctivitis; Drug Tolerance; Epinephrine; Eye Disease | 1979 |
Effects of topical 1-epinephrine and dipivalyl epinephrine on intraocular pressure and pupil size in the normotensive and glaucomatous Beagle.
Topics: Animals; Dog Diseases; Dogs; Epinephrine; Glaucoma; Intraocular Pressure; Ophthalmic Solutions; Pupi | 1978 |
Long-term drift and timolol therapy: possible role for pulsed therapy.
Topics: Aged; Aged, 80 and over; Drug Administration Schedule; Epinephrine; Humans; Intraocular Pressure; Lo | 1992 |
Delayed filtering bleb encapsulation.
Topics: Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular P | 1992 |
Intraocular pressure-dependent retinal vascular change in adult chronic open-angle glaucoma patients.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Chronic Disease; Epinephri | 1991 |
Ocular effects of dipivalyl esters of epinephrine and alpha-methylepinephrine.
Topics: Animals; Dose-Response Relationship, Drug; Epinephrine; Female; Ganglionectomy; Intraocular Pressure | 1990 |
The role of apraclonidine hydrochloride in laser therapy for glaucoma.
Topics: Acetazolamide; Adult; Aged; Animals; Clonidine; Epinephrine; Female; Glaucoma, Open-Angle; Humans; I | 1989 |
Drugs and glaucoma.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carbonic Anhydrase Inhibitors; Drug Combinations; Drug Impla | 1986 |
pH dependency of effect of topically applied dipivefrine hydrochloride on intraocular pressure and pupil size in rabbits: comparative studies with epinephrine.
Topics: Administration, Topical; Animals; Blinking; Dose-Response Relationship, Drug; Epinephrine; Hydrogen; | 1988 |
[Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
Topics: Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Guanethidine; Humans; Intraocular Pres | 1987 |
Therapeutic response interactions between timolol maleate and dipivefrin hydrochloride.
Topics: Aged; Aged, 80 and over; Drug Synergism; Drug Therapy, Combination; Epinephrine; Female; Glaucoma; H | 1987 |
[Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure].
Topics: Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Guanethidine; Humans; Intraocular Pres | 1986 |